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Edited by Gianni CesareniAbstract Interferon (IFN) cs ability to localise in the nucleus
and function in gene activation has been known for some time,
although the role of the conventional nuclear transporting impor-
tin molecules is unclear. Here, we demonstrate for the ﬁrst time
the direct recognition of IFNc and an IFNc mimetic peptide by
IMPa and the IMPa/b heterodimer, where the IFNc mimetic
shows higher aﬃnity. Signiﬁcantly, this correlates well both with
in vivo ability to target green ﬂuorescent protein to the nucleus in
transfected cells as determined by quantitative confocal laser
scanning microscopy, as well as GAS promoter activity of a
luciferase reporter. This has important implications for IFNcs
anti-viral action, and the potential use of the IFNc mimetic in
antiviral therapies.
Structured summary:
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with IMP beta (uniprotkb:Q6GTI5) and IMP alpha (uniprotkb:
P52293) by enzyme linked immunosorbent assay (MI:0411)
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Nuclear localisation of polypeptide ligands such as inter-
feron c (IFNc), growth hormone, and members of the ﬁbro-
blast and epidermal growth factor families has been known
for a number of years [1–5]. Importantly in this context, the
nuclear function of these ligands has become clearer more re-
cently, appearing to relate strongly to speciﬁc gene activation
[6], and regulation of cell proliferation/oncogenic potential
[2,4], putting into question the dogma that ligands signal solely
by interaction with the extracellular domain of membrane
receptors.
IFNc is a classic example of a nuclear localising/nuclear sig-
nalling ligand [7–11], appearing to have a strongly basic nucle-
ar localisation signal (NLS; 126RKRKRSR) resembling similar
sequences from viral gene products, with intact IFNc having
been shown to undergo nuclear translocation [12,13]. Signiﬁ-
cantly, the NLS of IFNc can be replaced with the well-charac-
terised NLS from SV40 large tumor-antigen (T-ag), without
any loss of biological activity [9]. NLSs conventionally confer
eﬃcient nuclear import through the fact that they are recogni-
sed with high aﬃnity by members of the importin (IMP) super-
family of nuclear transport molecules. The IMPs recognize
NLS-containing cargoes, and ferry them into the nucleus via
a series of speciﬁc interactions with components of the nuclear
pore, as well as the monomeric guanine nucleotide binding
protein Ran. Although there are many NLS-dependent path-
ways for transport into the nucleus, the best understood is that
mediated by the IMPa/b heterodimer, where IMPa within the
heterodimer binds the NLS, and IMPb mediates the interac-
tions with the nuclear pore and Ran to eﬀect translocation into
the nucleus [14]. IMP interactions with IFNc have not been
examined, although IFNc complexed with one of the IFNc
receptor (IFNGR1) subunits is believed to be responsible for
localising the STAT1a transcription factor in the nucleus in
IMPa/b-dependent fashion, dependent on the IFNc NLS [8].
Subsequent to internalization of IFNc [10], the IFNc/
IFNGR1/STAT1 complex is recruited to the promoters of
genes activated by IFNc, with IFNGR1 itself functioning as
a transcription factor with transactivational activity [6].
There are only seven STAT transcription factors that re-
spond to over 60 distinct ligands that use these factors for gene
activation [15]; where tested, all of these diﬀerent receptor sys-
tems involve receptor nuclear translocation. Understanding
IFNc nuclear import thus relates integrally to mechanisms ofblished by Elsevier B.V. All rights reserved.
Table 2
Binding of importin a and a/b to IFNc protein and peptides as
quantiﬁed using an ELISA-based binding assay
Protein Kd (nM)
a
IMP a IMP ab
mIFNc 175 ± 33 (3) 73 ± 17 (2)
mIFNc mimetic 1.8 ± 0.96 (3) 0.49 ± 0.17 (3)
mIFNc (95–125) 216 ± 99 (3) 167 ± 28 (4)
mIFNc (121–132) 241 ± 37 (2) 15 ± 3 (3)
mIFNc (121–132) NLSmut 583 ± 350 (2) 100 ± 65 (3)
T-ag 111–135-b-gal 146 ± 78 (2) 3 ± 1.3 (3)
aResults (mean ± S.E.M, with n in parentheses) were derived using an
ELISA - based binding assay as described in Section 2, and exempliﬁed
in Fig. 1B and C.
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subsequent development of mimetics of particular ligands of
therapeutic interest such as IFNc. In this study the interactions
of IFNc with IMPs are examined for the ﬁrst time, in addition
to examining the role of IFNc nuclear localisation in GAS-
dependent gene activation. Importantly, we show that IFNc
is recognised with high aﬃnity by IMPa/b, dependent on its
NLS, and that this is central to IFNcs nuclear localising abil-
ity. Intriguingly, a truncated derivative, the IFNcmimetic pep-
tide 95–132, shows higher aﬃnity of recognition by IMPs,
enhanced nuclear localising abilities, and higher gene activa-
tion activity, implying that it has all the properties of a potent
anti-viral agent.2. Materials and methods
2.1. Peptide synthesis
Synthesis of peptides using Fmoc chemistry and their puriﬁcation
were performed as described [16]. The peptide sequences are listed in
Table 1. Full length IFNc was from PBL interferon (Piscaraway, NJ).
2.2. Cell culture and CLSM analysis
COS-7 African green monkey kidney cells were maintained in
DMEM supplemented with 10% FCS in a 5% CO2 atmosphere at
37 C. COS-7 cells, 70–80% conﬂuent were transfected with 1.5 lg of
plasmid using Lipofectamine 2000 (Invitrogen), according to the man-
ufacturers instructions. Subcellular localisation of GFP-IFNc fusion
proteins was visualized in living cells 24 h after transfection by CLSM
(BioRAD MRC600, BioRad Laboratories, Hercules, CA), using a Ni-
kon 40· water immersion lens. The nuclear to cytoplasmic ratio (Fn/c)
was determined as previously [17,18] using the Image J 1.35i public do-
main software (NIH), from single cell measurements for each of the
nuclear (Fn) and cytoplasmic (Fc) ﬂuorescence, subsequent to the sub-
traction of ﬂuorescence due to autoﬂuorescence/background.
2.3. ELISA-based binding assay
An established ELISA-based assay [19–21] was used to determine
the binding aﬃnity of IMP subunits to the mIFNc protein and peptide
derivatives thereof. mIFNc protein and T-ag 111-135-b-gal fusion pro-
tein were coated onto 96-well microtiter plates at 1 lg/well, with pep-
tides coated at 4 pmol/well. Wells were then incubated with increasing
concentrations of IMPa-GST or IMPa/IMPb-GST subunits. Bound
IMP-GST was detected using an anti-GST primary antibody, an alka-
line phosphatase-coupled secondary antibody, and the substrate
p-nitrophenyl phosphate [19]. Data were ﬁtted as previously
[19,22,23] to determine the apparent dissociation constant (Kd).
2.4. Plasmid constructs for GFP-IFNc
Plasmid phrGFPII-C encoding GRP from Stratagene (La Jolla,
CA), was used to fuse the diﬀerent IFNc and IFNc mimetic peptide
sequences to the GFP C-terminus. Brieﬂy, A plasmid with complete
coding sequence for murine IFNc was obtained from ATCC (Manas-
sas, VA), and used as a PCR template to generate sequences encoding
non-secreted IFNc and the IFNc mimetic as well as their NLS mu-
tants. The primers used for the synthesis of non-secreted IFNc
spanned amino acids 1–132; to generate the NLS mutant, a reverse pri-Table 1
Sequence of peptides used in this study
Peptide
mIFNc mim
mIFNc mimNLSmut
mIFNc (95–125)
mIFNc (121–132)
mIFNc (121–132)NLSmut
aAll peptides (single letter amino acid code) are derived from the sequence of m
accordingly. The NLS region is in bold, with substitutions from wild type inmer encoding 126AAAAASA was used. The sequence encoding the
IFNc mimetic peptide was generated by PCR using primers covering
amino acids 95–132, with a reverse primer encoding 126AAAAASA
used to generate the NLS mutant derivative thereof. All PCR products
above were fused in frame with GFP at the C-terminus in the plasmid
phrGFPII-C, and DNA sequencing performed to conﬁrm the integrity
of all constructs.
2.5. Reporter gene assays
The plasmid pGL3 promoter, which expresses the ﬁreﬂy luciferase
was obtained from Promega (Madison, WI). A sequence containing
three copies of the GAS promoter element from human IRF-1 gene,
5 0-AGCCTGATTTCCCCGAAATGACGCG-3 0, was inserted in the
multiple cloning site of pGL3. The plasmid containing the coding se-
quence for IFNc was from ATCC (Manassas, VA). The sequence of
the complete secreted form of IFNc was ampliﬁed by PCR and intro-
duced downstream of the CMV promoter in the eukaryotic expression
vector pShCMV (Stratagene, La Jolla, CA). For the mimetic peptide,
the sequence of IFNc amino acids 95–132 was ampliﬁed by PCR and
introduced similarly into plasmid pShCMV. A constitutively expressed
thymidine kinase promoter driven Renilla luciferase gene (pRL-TK)
was used as an internal control in all of the reporter plasmid transfec-
tions. WISH cells were seeded in 12-well plates at 50% conﬂuency. The
next day, 200 ng of GAS promoter-driven ﬁreﬂy luciferase [6] and
10 ng of pRL-TK were cotransfected with 200 ng (high) or 50 ng
(low) of a plasmid expressing the non-secreted IFNc or IFNc mimetic
peptide. One day later, the cell lysates were used to assay for ﬁreﬂy and
Renilla luciferase, using a dual luciferase assay kit from Promega,
according to the manufacturers instructions. Luciferase activity in rel-
ative luciferase units was standardised by dividing ﬁreﬂy by Renilla
luciferase activity in each sample.3. Results and discussion
3.1. Importin a/b recognizes mIFNc with high aﬃnity: enhanced
binding of the mIFNc mimetic
Although IFNc is known to localise in the nucleus in many
diverse cellular contexts [1,6–13], its interactions with IMPs
have not been reported. An established ELISA-based binding
assay was used to assess the binding of IMPs to murine IFNcAmino acid sequencea
AKFEVNNPQV QRQAFNELIR VVHQLLPESS LRKRKRSR
AKFEVNNPQV QRQAFNELIR VVHQLLPESS LaaaaaSa
AKFEVNNPQV QRQAFNELIR VVHQLLPESS L
PESS LRKRKRSR
PESS LRKaaaSR
ature form of the corresponding mouse IFNc sequence and numbered
lower case.
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Fig. 1. High aﬃnity recognition of IFNc mimetic peptide compared to IFNc and the truncated 95–125 derivative by IMP a and the a/b heterodimer.
(A) Schematic representation of the IFNc showing the mimetic peptide region along with other truncations and NLS mutations used in this study.
(B) Microtiter plates were coated with mIFNc (A, left) or a control b-gal fusion protein containing the T-ag 111–135 including the NLS or the
indicated mIFNc peptides and then incubated with increasing amounts of IMPa or a/b complex (see Section 2). Binding curves were ﬁtted for the
function B = Bmax (1  ekx), where the Kds represent the concentration of IMP a and/or a/b complex yielding half-maximal binding. The regression
for the curve ﬁts in all cases were >0.98. The results are from a single typical experiment with pooled data shown in Table 1.
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compared to those for the control molecule T-ag 111–135-b-
gal which contains the well-characterised IMPa/b recognised
NLS of T-ag. Protein/peptides were coated onto microtiter
plates and incubated with increasing amounts of IMPa-GST
or preformed IMPa/b-GST heterodimer, and binding quanti-
tated subsequent to sequential incubations with antibodies spe-
ciﬁc to GST and an alkaline-phosphatase-labeled secondary
antibody [19,21].
Both mIFNc and the mIFNc mimetic peptide were found to
be recognised by IMPa/b with high aﬃnity (apparent dissoci-
ation constants,Kds, of 72 and 0.5 nM, respectively), implying
that IMPa/b is likely to be the mediator of nuclear import of
IFNc and/or protein complexes containing it. The aﬃnity of
binding of IMPa for both mIFNc and the mIFNc mimetic
peptide was about 2–3 times lower than that for the IMPa/b
heterodimer. This is consistent with results for other conven-
tional NLS-containing cargoes of IMPa/b such as T-ag [19–
21], where IMPa recognizes NLS-containing proteins with
much lower aﬃnity in the absence of IMPb. The mIFNc 95–
125, 121–132 and 121–132 NLSmut peptides showed no signif-GFP-IFNγ
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Fig. 2. IFNc or IFNc mimetic can target GFP to the nucleus dependent
indicated GFP-IFNc constructs 21 h post-transfection of Cos-7 cells compar
analysis, performed using the Image J software, for the nuclear to cytoplasmic
(Fc) ﬂuorescence). p-Values indicate signiﬁcant diﬀerences between Fn/c valuicant binding by IMPa, while the binding aﬃnity of the IFNc
mimetic peptide for IMPa/b was >300 times higher than that
for mIFNc 95–125 (Table 2), clearly indicating that the NLS
(126RKRKRSR) is critical for IMP binding. The aﬃnity of
mIFNc 121–132 peptide for IMPa/b (Kd of 15 nM) was 30-
fold lower than that of the mIFNc mimetic peptide, but 5–
11-fold higher than that of mIFNc 95–125, 121–132 NLSmut
or mIFNc itself (see Table 2). Overall, the results indicate that
IFNc mimetic peptide shows much higher IMPa/b binding
aﬃnity than full length IFNc, and are consistent with previous
ﬁndings [7,8,16] that IFNc contains a functional NLS (see also
below). The fact that IFNc is recognised by IMPa/b in appar-
ently conventional fashion, in contrast to reports of binding of
the transcription factor STAT1 to a non-conventional site on
IMPa [24], would appear to be consistent with the idea that
nuclear translocation of STAT1 is likely to be mediated by
IMPa/b interaction with IFNc, rather than STAT1, with
IFNGR1 as the adaptor between the two (see [1,6]). That full
length mIFNc did not bind IMPs as well as the truncated mi-
metic peptide is probably attributable to conformational prop-
erties that hinder access to the NLS in the full protein [7,16].GFP
IFNγ mim IFNγ mim
NLSmut
mut
on the NLS sequence 126–132. (A) CLSM images are shown for the
ed to GFP alone (right). (B) Results (mean ± S.E.M., n > 43) of image
ratio (Fn/c representing measurements of nuclear (Fn) and cytoplasmic
es.
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dependent on NLS
To correlate the results for IMP binding with in vivo nuclear
localisation ability, COS7 cells were transfected to express var-
ious IFNc-GFP-fusion protein constructs and the extent of
nuclear accumulation assessed by quantitative CLSM. As evi-
dent from Fig. 2, both IFNc and the IFNc mimetic could tar-
get GFP eﬃciently to the nucleus, consistent with the idea that
IFNc contains a functional NLS. Interestingly, the IFNc mi-
metic peptide conferred a signiﬁcantly higher (p = 0.0037) level
of nuclear accumulation upon GFP than full length IFNc (Fig.
2A left column; Fn/c values of 12.5 and 6.5, respectively – Fig.
2B). Mutations within the NLS had a signiﬁcant (p < 0.0001)
eﬀect, abrogating nuclear accumulation of either GFP fusion
protein (Fig. 2A, second column), to levels observed for
GFP alone (Fig. 2A far right; Fn/c value of c 1.2, Fig. 2B).
The clear implication was that the IFNc NLS is functional
for nuclear targeting in intact cells.
3.3. The IFNc mimetic has higher transactivation activity than
the non-secreted IFNc at the GAS promoter
To test the ability of the various IFNc-derivatives to activate
the IFNc activated sequence (GAS) promoter, plasmids
expressing non-secreted IFNc or IFNc mimetic peptide were
transfected into WISH cells together with a reporter plasmid
expressing ﬁreﬂy luciferase from a GAS promoter (Fig. 3),
and a constitutively expressed Renilla luciferase plasmid as
an internal control to standardise relative luciferase units.
When high amounts of the plasmid were used for transfection,
non-secreted IFNc and IFNc mimetic caused 3- and 5-fold in-
creases in GAS promoter activity respectively, compared to the
empty vector. Similarly, at low amounts of the transfected
plasmids, 2- and 3.5-fold increases in GAS promoter activity
were observed with non-secreted IFNc and IFNc mimetic,0
5
10
15
20
25
30
35
R
el
at
iv
e 
lu
ci
fe
ra
se
 u
ni
ts
IFNγ IFNγ
mim
IFNγ IFNγ
mim
alone
+ pGAS-Luc
200 ng 50 ng
Fig. 3. IFNc mimetic peptide is more active than IFNc at the GAS
promoter. WISH cells were co-transfected with a vector containing the
promoter element of IFNc activated sequence (GAS) linked to ﬁreﬂy
luciferase and a vector with constitutively expressed Renilla luciferase
as an internal control. The other plasmids used for the expression of
non-secreted IFNc (aa 1–132) and IFNc mimetic (aa 95–132) are
abbreviated as IFNc and IFNc mim, respectively. High (200ng) or low
(50 ng) amounts of plasmid DNA expressing IFNc or IFNc mim were
used for co-transfection carried out in triplicate. Relative luciferase
activity was measured 24 h after transfection, and is presented as
mean ± S.D.respectively. Clearly, IFNc mimetic peptide was more active
at the GAS promoter than non-secreted IFN, which is com-
pletely consistent with its increased ability to be recognised
by IMPa/b (Fig. 1) and its superior in vivo activity in targeting
GFP to the nucleus (Fig. 2). We have shown previously that
non-secreted IFNc can recapitulate essentially all of the prop-
erties of secreted IFNc in terms of intracellular signalling via
the cytoplasmic domain of IFNc receptor subunit, IFNGR1
[8,25]. Thus, consistent with the higher binding of IFNc mi-
metic peptide to IMPs, the IFNc mimetic is more eﬃcient in
activating transcription at the GAS promoter.4. Conclusion
The results here document for the ﬁrst time that IFNc is
recognised by the Impa/b heterodimer in conventional fashion,
dependent on its NLS (amino acids 126–132), and that this is
central to the role of IFNc in the nucleus in GAS promoter
activation. Intriguingly, the truncated mIFNc mimetic peptide
binds to Impa/b with higher aﬃnity, and, as a result, has en-
hanced nuclear localisation activity, as well as higher GAS
promoter activation activity, emphasizing the importance of
the nuclear signalling role of IFNc, thereby resembling that
of other polypeptide ligands such as the ﬁbroblast and epider-
mal growth factors [1–5]. Importantly, in the sequence of
events that lead from ligand/receptor interaction culminating
in expression of speciﬁc genes, it would appear that the eﬃ-
ciency of nuclear import of ligand/receptor may be a critical
factor in target gene activation. Since the IFNc mimetic pep-
tide shows stronger binding to IMPa/b than IFNc itself, as
well as a greater ability to enhance transactivation of IFNc
promoters, it would appear to have all the desirable features
to enhance anti-viral responses [26], underlining its potential
as an anti-viral therapeutic.
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